慢性乙型肝炎患者外周血Th17和Treg细胞及其表面CXCR3的表达
[Abstract]:Background and objective there are about 93 million chronic HBV infections in China, including 20 million chronic hepatitis B patients. It is well known that hepatitis B virus causes varying degrees of hepatocyte damage, not because the virus directly kills the liver cells, but because of the immune response induced by the virus. Among them, CD4 T lymphocytes can produce a variety of cytokines to assist specific and non-specific effector cells to kill the virus, thus becoming an important part of cellular and humoral immune response. IL-17 adjuvant T lymphocytes and Foxp3 regulatory T lymphocytes are new type of CD4 T lymphocytes which have been studied in recent years and play an important role in chronic hepatitis B. It has been shown that circulating IL-17 T cells (generally referred to as Th17 cells) accumulate in the liver of patients with chronic hepatitis B, and the frequency of expression increases with the severity of hepatitis. The function of Foxp3 T cells is opposite to that of Th17 cells. It can inhibit the HBV antigen-specific T cell response and control the progression of chronic hepatitis B. The balance between Th17 and Treg cells plays an important role in the immune homeostasis of chronic hepatitis B. However, the expression of CXCR3 and its chemokine ligand IP-10 have been reported to be associated with chronic hepatitis B, and the expression of CXCR3 and its chemokine ligand IP-10 have been reported to be associated with chronic hepatitis B. Little is known about the expression of CXCR3 on the surface of Th17 and Treg cells and its immunomodulation. Therefore, we studied the expression frequency of CXCR3 on the surface of CD4 IL-17 T and CD4 CD25 Foxp3 T lymphocytes in healthy subjects and patients with chronic hepatitis B of different degrees, and explored the relationship between CXCR3 Th17 and Treg cells and liver damage. Methods Peripheral blood 2ml of patients with chronic hepatitis B and healthy subjects were collected to exclude acute and chronic liver injury caused by other causes. According to the classification guidelines of the Chinese Medical Association for chronic hepatitis B in 2000, they were divided into healthy control group. Mononuclear lymphocytes were extracted from peripheral blood of mild to moderate chronic hepatitis group and chronic severe hepatitis group. Th17 and Treg cell antigen specific labeling antibody and CXCR3 monoclonal antibody were labeled by flow cytometry. FACSCalibur flow cytometry was used to detect the proportion of Th17,Treg cells and the expression of CXCR3 on its surface. The transwell technique was used to analyze the chemotaxis of Th17 and Treg cells by using transwell technique. SPSS 18.0 software was used to analyze the chemotaxis of Th17 and Treg cells. Results compared with the normal control group, the percentage of Th17 and Treg cells in peripheral blood of the hepatitis group increased, especially in the chronic severe hepatitis group, but the proportion of CXCR3 cells in the Th17 cells in the hepatitis group was not different from that in the healthy group. However, the proportion of CXCR3 cells in Treg cells in hepatitis group was significantly higher than that in healthy group, especially in chronic severe hepatitis group. The proportion of CXCR3 Th17 cells and CXCR3 Treg cells increased with the increase of liver injury (ALT), and the more the concentration of chemokine IP-10, the more CXCR3 Th17 and Treg cells were chemotaxis. Conclusion the proportion of Th17 and Treg cells in peripheral blood of patients with chronic hepatitis B increased with the increase of inflammatory injury. The expression of CXCR3 on the surface of these immune cells was different in different states. The expression of CXCR3 on the surface of Th17 cells could reflect the degree of liver inflammation in chronic hepatitis, and the ligand IP-10 could interact with CXCR3 and play a chemotactic effect on Th17 and Treg cells.
【学位授予单位】:华中科技大学
【学位级别】:硕士
【学位授予年份】:2013
【分类号】:R512.62
【参考文献】
相关期刊论文 前4条
1 ;Expression of CXC chemokine IP-10 in patients with chronic hepatitis B[J];Hepatobiliary & Pancreatic Diseases International;2008年01期
2 ;Relationship between the expression of IP-10 and IP-10 mRNA in peripheral blood and HBV DNA level in patients with cirrhosis[J];Hepatobiliary & Pancreatic Diseases International;2010年03期
3 王建设,朱启昒,张婷,俞蕙;粒细胞-巨噬细胞集落刺激因子联合乙肝疫苗治疗宫内乙型肝炎病毒感染慢性携带儿童的研究(英文)[J];Chinese Medical Journal;2002年12期
4 Virasakdi Chongsuvivatwong;Hutcha Sriplung;Alan Geater;;Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B:A randomized controlled study[J];World Journal of Gastroenterology;2006年41期
本文编号:2246845
本文链接:https://www.wllwen.com/yixuelunwen/chuanranbingxuelunwen/2246845.html